All relevant costs and consequences should be measuredBMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6971.61c (Published 07 January 1995) Cite this as: BMJ 1995;310:61
- Rachel Hardie
- Lecturer Department of Community Medicine, University of Hong Kong, Hong Kong
EDITOR,—On the basis of a comprehensive economic evaluation R H Behrens and J A Roberts conclude that “a national policy of immunising all travellers against typhoid and hepatitis A does not seem to be cost beneficial to the community.”1 While in principle such evaluations should help guide public health policy, considerable uncertainty surrounds many of the estimates used, and their conclusion should not compromise public health advice on the need for vaccination for certain categories of travellers.
Certain costs …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial